Home - Translational Lung Cancer Research

AME and Wolters Kluwer aim to expand access to global medical research through new collaboration

The agreement broadens the reach of nearly 50 Open Access titles, contributing globally to over 5,000 articles

October 2, 2025 — Wolters Kluwer Health announced a new collaboration with AME Publishing Company, an Open Access publisher specializing in medical journals and books, headquartered in Hong Kong, China.

New Impact Factor for Translational Lung Cancer Research: 3.5

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has attained its latest impact factor update for the 2024 citation year: 3.5.

Translational Lung Cancer Research 2024 CiteScore Released: 6.9

We are pleased to announce that the Translational Lung Cancer Research (TLCR) has achieved its 2024 CiteScore: 6.9, ranking 92 out of 415 journals in the Oncology category. This milestone underscores our ongoing commitment to publishing impactful research in the field.

Interviews with Outstanding Authors (2025)

In 2025, many authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors, with a brief interview of their thoughts and insights as authors. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Reviewer of the Month (2025)

In 2025, TLCR reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

TLCR Annual Report 2024

Welcome to the 2024 annual report for Translational Lung Cancer Research. In 2024, the TLCR has continued its mission to increase the quality and impact of the journal, and to provide readers with a novel, well-organized, informative, enlightening and educational journal.

We would like to sincerely thank our Editorial Board Members, Guest editors, Reviewers, Authors, Readers for all your supports and contributions to TLCR in 2024, and we look forward to continuing our work with you in the new year.

Interviews with Editorial Board Members

TLCR features a distinguished editorial board, the members of which continue to instill the power of their expertise for the journal’s development. By launching this column, we are glad to introduce to you some of them in the form of interviews, in which they will share their unique career experiences and perspectives. We believe their insights will shed light on the knowledge of related fields.

Interviews with Guest Editors

Over the years, a number of TLCR guest editors have made valuable contributions to the journal. This column features interviews with our guest editors, who graciously share their experience in scientific careers and provide insightful perspectives on the special series.

‹ ›

Vol 14, No 10 (October, 2025)

Articles in Press

Past Issues

About tlcr

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

General editorial enquiries:
Email: editor@tlcr.org
Copyright related contact:
Email: permissions@amegroups.com
Commercial Sales contact (Reprints, advertising, etc.):
Email: sales@amegroups.com

Editorial Commentary

Molecular minimal residual disease in resected non-small cell lung cancer: “flattening the curve”

Marc G. Denis

PDF Pages: 4180-4183 Full Text (26) Peer Review File COI Form Open Access

KRAS under attack: recent advances in targeted therapies involving G12C inhibitors and XPO1 inhibition

Markus Falk, Stefanie Schatz, Markus Tiemann, Joachim H. Ficker, Wolfgang M. Brueckl

PDF Pages: 4184-4186 Full Text (35) Peer Review File COI Form Open Access

Original Article

Survival after wedge resection, segmentectomy and lobectomy for clinical stage IA non-small cell lung cancer: a systematic review and network meta-analysis

Cien Sun, Jiang Jin, Jiawen Chen, Hao Liu, Pasan Witharana, Minghui Yang, Zimin Wang, Ying Zhang, Pengfei Sheng, Yutao Chen, Chengchu Zhu, Jianfei Shen

PDF Pages: 4187-4209 Full Text (66) Reporting Checklist Peer Review File COI Form Open Access

Analysis of second-line therapy in patients with prior pneumonitis receiving first-line combination immunotherapy for advanced non-small cell lung cancer

Noriyuki Ebi, Hiroyuki Inoue, Makoto Fujimoto, Ami Hirata, Maiya Chen, Natsumi Kushima, Yuuka Sakaki, Takato Ikeda, Yuki Shundo, Toyoshi Yanagihara, Masaki Fujita

PDF Pages: 4210-4220 Full Text (44) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Predicting the prognosis of patients with lung adenocarcinoma treated with third-generation EGFR-TKI alone using nomograms based on CT radiomic and clinicopathological factors

Junfeng Zhao, Xinhang Gu, Jiaxiao Geng, Ying Li, Yan Wang, Chengxin Liu

PDF Pages: 4221-4234 Full Text (40) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Single-cell RNA profiling reveals an immunosuppressive microenvironment in EGFR double-mutant non-small cell lung cancer

Jiao Yang, Jun-Wei Su, Hong-Rui Li, Mei-Mei Fang, Xu-Hui Guan, Xiao-Cheng Lin, Ke-Jun Liu, Li-Xu Yan, Xu-Chao Zhang, Xue-Ning Yang, Wen-Zhao Zhong, Hua-Jun Chen, Jia Liu, Wendy Wu, Jin-Ji Yang

PDF Pages: 4235-4255 Full Text (75) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Investigation of non-completion factors for durvalumab maintenance therapy in locally advanced non-small cell lung cancer

Masaaki Kotake, Yuki Sakai, Satoshi Watanabe, Toshiaki Kikuchi, Akira Toyama

PDF Pages: 4256-4267 Full Text (44) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Feasibility of next-generation sequencing using bronchoscopic specimens in potentially resectable non-small cell lung cancer

Kaito Yano, Yuji Matsumoto, Hideaki Furuse, Keigo Uchimura, Tatsuya Imabayashi, Keisuke Asakura, Takaaki Tsuchida

PDF Pages: 4268-4284 Full Text (38) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Influencing factors and prediction of growth heterogeneity in solid nodule non-small cell lung cancer based on artificial intelligence: a prospective study

Jiaqi Chen, Jianing Liu, Linlin Qi, Fenglan Li, Shulei Cui, Jianwei Wang

PDF Pages: 4285-4300 Full Text (36) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Deep learning radiomics and ¹⁸F-FDG PET/CT imaging: mediastinal lymph node characteristics as predictors of metastasis in non-small cell lung cancer

Furui Duan, Hanyu Zu, Rui Zhang, Yan Li, Yu Zhao, Xuewei Wang, Minghui Zhang, Ping Li, Dalong Wang

PDF Pages: 4301-4314 Full Text (41) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Evaluation of gefitinib alone or combined with bevacizumab in patients with EGFR L858R-positive advanced non-squamous non-small cell lung cancer: an open-label, randomized, phase 2 trial (BEVA-FLFX-001) with exploratory analysis of plasma biomarkers

Xinmin Zhao, Xianghua Wu, Huijie Wang, Hui Yu, Si Sun, Zhihuang Hu, Ying Lin, Yao Zhang, Bo Yu, Zhenhua Wu, Kangli Xiong, Cuicui Liu, Song Wang, Hua Bao, Qiuxiang Ou, Jialei Wang

PDF Pages: 4315-4330 Full Text (36) Reporting Checklist Trial Protocol Data Sharing Statement Peer Review File COI Form Open Access

Treatment intensity-dependent association between the number of oral hypoglycemic agents and insulin use and lung cancer risk in patients with type 2 diabetes

Chiwook Chung, Kyu Na Lee, Kyungdo Han, Dong Wook Shin, Sei Won Lee

PDF Pages: 4331-4342 Full Text (39) Reporting Checklist Peer Review File COI Form Open Access

Treatment outcome and safety of durvalumab after concurrent chemoradiation in very elderly patients with unresectable stage III non-small cell lung cancer

So Jeong Kim, Na Young Kim, Soo Jie Chung, In Gyu Hyun, Yohwan Yeo, Ji Young Park, Seung Hun Jang, Taehee Kim, Yun Su Sim, Chang Youl Lee, Junghyun Kim

PDF Pages: 4343-4356 Full Text (40) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

The prognostic importance of the pan-immune-inflammation value (PIV) in lung cancer: a systematic review and meta-analysis

Guangji Cao, Quanqing Liu, Hao Wen, Yuan Zeng

PDF Pages: 4357-4370 Full Text (38) Reporting Checklist Peer Review File COI Form Open Access

A retrospective cross-sectional study of FGFR2b alterations in Chinese patients with advanced squamous non-small cell lung cancer: prevalence, programmed death-ligand 1 co-expression patterns, and association with clinical outcomes

Xiyuan Wang, Kaiwen Chi, Haiyue Wang, Shuguang Sun, Chunxia Ao, Jiongyan Li, Yuanjie Ge, Chen Yang, Yayuan Fu, Dongmei Lin, Renhong Tang, Wei Sun

PDF Pages: 4371-4383 Full Text (37) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Characterization of RET fusions via integrated DNA and RNA sequencing in early-stage non-small cell lung cancer: a retrospective study

Ying Ding, Gang Chen, Xiao He, Yuqian Shi, Chunhong He, Jiani C. Yin, Zhihong Zhang

PDF Pages: 4384-4397 Full Text (28) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Comparative outcomes of treatment with versus without definitive thoracic radiotherapy in locally advanced inoperable non-small cell lung cancer during the immunotherapy era: a Chinese real-world study

Xueru Zhu, Jun Liu, Ruxin Cai, Wen Feng, Jun Liu, Wen Yu, Xuwei Cai, Qin Zhang, Xiaolong Fu

PDF Pages: 4398-4411 Full Text (39) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Doxorubicin paclitaxel in pretreated advanced small-cell lung cancer: a large real-life retrospective study

Coraline Cheuvart, Paul Gougis, Luca Campedel, Clara Bourrachot, Camille Rolland Debord, Baptiste Abbar

PDF Pages: 4412-4421 Full Text (23) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Characteristics of patients with non-small cell lung cancer and either limited or extensive synchronous metastatic spread in Germany—a population-based cancer registry cohort study

Sophia Bertram, Antje Schliemann, Alexander Katalinic, Soo-Zin Kim-Wanner, Ron Pritzkuleit, Dorothee Twardella, Annika Waldmann

PDF Pages: 4422-4435 Full Text (31) Reporting Checklist Peer Review File COI Form Open Access

Overall survival and progression-free survival of patients with non-small cell lung cancer and either limited or extensive synchronous metastatic spread in Germany—a population-based cancer registry cohort study

Sophia Bertram, Antje Schliemann, Alexander Katalinic, Soo-Zin Kim-Wanner, Ron Pritzkuleit, Dorothee Twardella, Annika Waldmann

PDF Pages: 4436-4448 Full Text (31) Reporting Checklist Peer Review File COI Form Open Access

Association between soluble immune mediators and outcomes in patients with unresectable stage III non-small cell lung cancer treated with concurrent chemoradiotherapy followed by durvalumab

Takaaki Tokito, Koichi Azuma, Kenta Murotani, Norikazu Matsuo, Goushi Matama, Daiki Murata, Tetsuro Sasada, Tomoaki Hoshino

PDF Pages: 4449-4459 Full Text (31) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Deciphering the potential pathogeny of rare tracheal adenoid cystic carcinoma by single-cell RNA-sequencing

Jie Li, Yaping Long, Tao Wang, Haixu Hu, Yanju Yu, Jinfeng Li, Lijuan Zhang, Bo Yang, Yi Liu

PDF Pages: 4460-4474 Full Text (40) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Deep learning-based classification of pleural malignancy using medical thoracoscopic images

Yu Jin Hong, Se Hee Ha, Seong Hyeon Park, Jick Hwan Ha, Hyung Woo Kim, Bo Ra Lee, Sang Haak Lee, Chang Dong Yeo, Jong-Yeup Kim, Joon Young Choi

PDF Pages: 4475-4484 Full Text (32) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Incremental prognostic value of solid component volume ratio and entropy for pathological stage IA invasive lung adenocarcinoma after surgery

Zetao Liu, Xiaoqin Chen, Yanling Zheng, Xiongmu Tan, Yinqiu Wang, Linyan Huang, Jierui Zheng, Yongqian Yu, Chenglin Guo, Liqing Peng, Jiandong Mei

PDF Pages: 4485-4499 Full Text (33) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

SuFu somatic mutations are recognized as novel markers for genomic instability and tumor growth in lung adenocarcinoma

Ji-Hong Liu, Tao Zhang, Yan Wang, Meng-Si Zhang, Jian He, Xiang-Dong Zhou

PDF Pages: 4500-4513 Full Text (38) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Diagnostic utility of cryobiopsy for invasive mucinous lung adenocarcinoma

Atsushi Kosuge, Yuji Matsumoto, Hideaki Furuse, Kenya Sato, Jumpei Kashima, Satsuki Kishikawa, Masaya Yotsukura, Tomohiro Haruki, Yukihiro Yoshida, Shun-Ichi Watanabe, Yasushi Yatabe, Takaaki Tsuchida

PDF Pages: 4514-4526 Full Text (30) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Immunohistochemical analysis of p53 and LKB1 as predictive biomarkers of immune checkpoint inhibitor response in non-small cell lung cancer

Kazuo Tsuchiya, Tomo Tsunoda, Hisaki Igarashi, Kazuya Hattori, Taisuke Ito, Takuro Akashi, Yoshiyuki Oyama, Yasuhiko Kitayama, Masaki Ikeda

PDF Pages: 4527-4540 Full Text (34) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Fecal microbiota transplantation plus immune checkpoint inhibitor rechallenges in patients with advanced non-small cell lung cancer: a single-arm exploratory study

Yijia Du, Yanying Li, Min Yu, Yang Yu, Yan Zhang, Xianfeng Wang, Jianquan He, Lin Lin, Baolong Shen, Youling Gong, Jiang Zhu, Bingwen Zou, Yongmei Liu, Meijuan Huang, You Lu

PDF Pages: 4541-4559 Full Text (46) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Brief Report

Identification of a novel RSPO1-NUMT insertion in a LUAD patient cohort and the challenges and insights into NUMT detection highlighting the importance of reference genomes and population databases

Ilona Tietzova, Dana Sochorova, Petr Triska, Rebecca C. Rancourt, Marek Omelka, Eva Parobkova, Michael Allgäuer, Marc A. Schneider, Karsten Senghas, Laura V. Klotz, Marketa Tesarova

PDF Pages: 4560-4570 Full Text (38) Reporting Checklist Peer Review File COI Form Open Access

Review Article

Time toxicity in previously untreated metastatic or unresectable epidermal growth factor receptor-mutant non-small cell lung cancer: a clinical practice review

Won Jin Jeon, Bowon Joung, Padma Sri Katikaneni, Akshit Chitkara, Neha Agrawal, Kashyap Padmaraju, Ni Ya, Sarvnaz Sadrameli, Aakash Desai, Emerson Chen, Jeremy Cetnar, Rajat Thawani

PDF Pages: 4571-4575 Full Text (29) Peer Review File COI Form Open Access

A narrative review of imaging intratumor heterogeneity in non-small cell lung cancer: current advances

Ping Lin, Hongbin Wang, Bingrun Zou, Ziwei Zhu, Weimin Li, Bojiang Chen

PDF Pages: 4576-4603 Full Text (48) Reporting Checklist Peer Review File COI Form Open Access

The role of TRPA1 in lung cancer

Diarmuid O’Connor, Stephen P. Finn, Steven G. Gray

PDF Pages: 4604-4617 Full Text (23) Peer Review File COI Form Open Access

Neoadjuvant systemic therapy for pleural mesothelioma patients: a systematic review

Illaa Smesseim, Jo Raskin, Jacobus A. Burgers

PDF Pages: 4618-4627 Full Text (22) Reporting Checklist Peer Review File COI Form Open Access

Utility of bronchoalveolar lavage in checkpoint inhibitor pneumonitis evaluation: a narrative review

Senthuran Shivakumar, Sagun Parakh, Natalia Vukelic, Farzaneh Atashrazm, Vivek Naranbhai, Nicole Soo Leng Goh, Jessica Da Gama Duarte, Tracy Li-Tsein Leong

PDF Pages: 4628-4637 Full Text (56) Reporting Checklist Peer Review File COI Form Open Access

Immune-oncology-microbiome axis in lung cancer: from carcinogenesis to therapy—a narrative review

Mengyi Shen, Yueying Chen, Jiayan Chen, Jie Yin, Chunwei Xu, Dong Wang, Tangfeng Lv

PDF Pages: 4638-4657 Full Text (28) Reporting Checklist Peer Review File COI Form Open Access

Study Protocol

The impact of rurality, socioeconomic status, and health literacy on lung cancer screening uptake: a systematic review protocol

Apeksha Phulgirkar, Aaleyah Kelso, Rashmikaa Ranganathan, Rebecca N. Jerome, Jennifer A. Lewis, Lucy B. Spalluto

PDF Pages: 4658-4665 Full Text (22) Peer Review File COI Form Open Access

Local consolidative therapy for the primary tumor in EGFR-mutant advanced non-small cell lung cancer following osimertinib plus chemotherapy: a protocol for a single-arm, open-label, phase 2 trial

Mi-Hyun Kim, Hayoung Seong, Soo Han Kim, Jung Seop Eom

PDF Pages: 4666-4674 Full Text (30) Reporting Checklist Peer Review File COI Form Open Access

Case Report

The granulomatous pulmonary nodules induced by tislelizumab in advanced squamous NSCLC: a case report with challenging differential diagnosis

Yangyang Ma, Xinxin Chen, Yan Liang, Sili Wang, Yanwen Yao, Tangfeng Lv, Dongmei Yuan

PDF Pages: 4675-4681 Full Text (28) Reporting Checklist Peer Review File COI Form Open Access

Spontaneous regression of tumors post-chemotherapy in a patient with relapsed small cell lung cancer: a case report

Tomoha Miyaki, Shunichi Kataoka, Takehito Shukuya, Ayumi Yanai, Hitomi Shiozaki, Hiroaki Motomura, Taichi Miyawaki, Takuo Hayashi, Aritoshi Hattori, Kenji Suzuki, Kazuhisa Takahashi

PDF Pages: 4682-4687 Full Text (31) Reporting Checklist Peer Review File COI Form Open Access

Lung adenocarcinoma with ALK deletion of exons 6–20 with response to sequential ALK inhibitors: a case report

Kazuki Jinno, Tatsuya Imabayashi, Toshiyuki Tanaka, Kohei Yamamoto, Shunya Tanaka, Sayaka Uda, Tatsuya Yuba, Chieko Takumi

PDF Pages: 4688-4694 Full Text (32) Reporting Checklist Peer Review File COI Form Open Access

Pathological complete response in RET-positive non-small cell lung cancer: a case report of pralsetinib-based “sandwich” therapy

Qihua He, Xin Xu, DongMei Li, Yalei Zhang

PDF Pages: 4695-4703 Full Text (25) Reporting Checklist Peer Review File COI Form Open Access

Review Articles

Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 22 October 2013

PDF Pages: 354-363 Full Text (338833) Open Access

Editorial Commentary

Ground glass nodules with 5 years’ stability can grow after 10-year follow-up: do genetic features determine the fate?

Yoshihisa Kobayashi, Tetsuya Mitsudomi

Published online: 31 December 2019

PDF Pages: S425-S427 Full Text (87541) Open Access

Review Article

Non-small cell lung cancer: current treatment and future advances

Cecilia Zappa, Shaker A. Mousa

Published online: 30 June 2016

PDF Pages: 288-300 Full Text (78719) Open Access

Review Articles

Irreversible EGFR-TKIs: dreaming perfection

Lorenza Landi, Federico Cappuzzo

Published online: 14 January 2013

PDF Pages: 40-49 Full Text (70386) Open Access

Review Article

Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology

Jian-Wei Gao, Stefania Rizzo, Li-Hong Ma, Xiang-Yu Qiu, Arne Warth, Nobuhiko Seki, Mizue Hasegawa, Jia-Wei Zou, Qian Li, Marco Femia, Tang-Feng Lv, Yong Song, written on behalf of the AME Lung Cancer Collaborative Group

Published online: 28 February 2017

PDF Pages: 68-75 Full Text (60479) Open Access

Review Article

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Published online: 28 August 2014

PDF Pages: 242-249 Full Text (48190) Open Access

Review Article

Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatment

Tianli Zhang, Bing Wan, Yuan Zhao, Chuling Li, Hongbing Liu, Tangfeng Lv, Ping Zhan, Yong Song

Published online: 30 June 2019

PDF Pages: 302-316 Full Text (44098) Open Access

Review Article

Targeted therapy for non-small cell lung cancer: current standards and the promise of the future

Bryan A. Chan, Brett G.M. Hughes

Published online: 24 February 2015

PDF Pages: 36-54 Full Text (43445) Open Access

Review Article

Lung cancer prediction using machine learning and advanced imaging techniques

Timor Kadir, Fergus Gleeson

Published online: 14 June 2018

PDF Pages: 304-312 Full Text (42983) Open Access

Review Article

Ground-glass nodules of the lung in never-smokers and smokers: clinical and genetic insights

Yoshihisa Kobayashi, Chiara Ambrogio, Tetsuya Mitsudomi

Published online: 28 August 2018

PDF Pages: 487-497 Full Text (39900) Chinese (5862) Open Access

Review Article

The past, present and future of immunotherapy against tumor

Tao Jiang, Caicun Zhou

Published online: 24 June 2015

PDF Pages: 253-264 Full Text (39566) Open Access

Review Article

The epidemiology of lung cancer

Patricia M. de Groot, Carol C. Wu, Brett W. Carter, Reginald F. Munden

Published online: 14 June 2018

PDF Pages: 220-233 Full Text (34476) Open Access

Review Article

Lung cancer screening: nodule identification and characterization

Ioannis Vlahos, Konstantinos Stefanidis, Sarah Sheard, Arjun Nair, Charles Sayer, Joanne Moser

Published online: 14 June 2018

PDF Pages: 288-303 Full Text (33591) Open Access

Review Articles

KRAS mutant NSCLC, a new opportunity for the synthetic lethality therapeutic approach

Javier de Castro Carpeño, Cristóbal Belda-Iniesta

Published online: 03 April 2013

PDF Pages: 142-151 Full Text (32440) Open Access

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Published online: 11 October 2017

PDF Pages: 508-512 Full Text (32454) Open Access

Review Article

Molecular testing strategies in non-small cell lung cancer: optimizing the diagnostic journey

Jeffrey P. Gregg, Tianhong Li, Ken Y. Yoneda

Published online: 30 June 2019

PDF Pages: 286-301 Full Text (32348) Open Access

Consensus

Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)

Jianxing He, Hengrui Liang, Wei Wang, Andrey Akopov, Alberto Aiolfi, Keng-Leong Ang, Luca Bertolaccini, Kaican Cai, Qingdong Cao, Baojun Chen, Chang Chen, Chun Chen, Donglai Chen, Fengxia Chen, Jun Chen, Lei Chen, Mingwu Chen, Yongbing Chen, Zhuxing Chen, Chao Cheng, Dong Cui, Fei Cui, Tianyang Dai, Qinglong Dong, Paolo A. Ferrari, Raja M. Flores, Junke Fu, Soichiro Funaki, Marios E. Froudarakis, Xiangfeng Gan, Mingfei Geng, Jialong Guo, Qiang Guo, Yongtao Han, Jintao He, Kaiming He, Kyoji Hirai, Jian Hu, Shuqiao Hu, Jian Huang, Jun Huang, Wenfa Jiang, Kyung Soo Kim, Gabor Kiss, Fanyi Kong, Lan Lan, Xuefeng Leng, Bin Li, Gaofeng Li, Hecheng Li, Hefei Li, Heng Li, Jiwei Li, Xiaoqiang Li, Shuben Li, Yinfen Li, Zhuoyi Li, Yi Liang, Lixia Liang, Wenhua Liang, Yongde Liao, Wanli Lin, Xu Lin, Hongxu Liu, Hui Liu, Jixian Liu, Jun Liu, Xiang Liu, Zihao Liu, Xingzhao Lu, Qingquan Luo, Naiquan Mao, Qi Pan, Dazhi Pang, Jun Peng, Jun Peng, Eugenio Pompeo, Rulin Qian, Kun Qiao, Bassam Redwan, Zi Sang, Wenlong Shao, Jianfei Shen, Weiyu Shen, Sook-Whan Sung, Wenfang Tang, Tianhu Wang, Guangsuo Wang, Haitao Wang, Huien Wang, Jiyong Wang, Wen Wang, Yongyong Wang, Zhenyuan Wang, Li Wei, Wei Wei, Hao Wu, Jie Wu, Zhaohua Xia, Chenyang Xu, Enwu Xu, Hai Xu, Ning Xu, Quan Xu, Rongyu Xu, Shun Xu, Chaokun Yang, Hanyu Yang, Shengli Yang, Jun Yi, Guangjian Zhang, Hao Zhang, Jia Zhang, Man Zhang, Xiao Zhang, Yajie Zhang, Zhe Zhang, Zhifeng Zhang, Honglin Zhao, Jian Zhao, Xiaodong Zhao, Jianping Zhou, Yanran Zhou, Chengchu Zhu, Shaojin Zhu, Xinhai Zhu, Jian Cui, Yubo Yan, Ke-Neng Chen

Published online: 28 August 2021

PDF Pages: 3503-3519 Full Text (30669) COI Form Open Access

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Published online: 19 April 2015

PDF Pages: 156-164 Full Text (29629) Open Access

Review Articles

New TNM classification: achievements and hurdles

Peter Goldstraw

Published online: 17 August 2013

PDF Pages: 264-272 Full Text (29018) Open Access

Review Articles

Angiogenesis in cancer: anti-VEGF escape mechanisms

Gerald W. Prager, Marina Poettler, Matthias Unseld, Christoph C. Zielinski

Published online: 18 February 2012

PDF Pages: 14-25 Full Text (28968) Open Access

Full Most Read article list >>

Original Article

Prognostic value of Twist in lung cancer: systematic review and meta-analysis

Junli Zeng, Ping Zhan, Guannan Wu, Wen Yang, Wenjun Liang, Tangfeng Lv, Yong Song

BRAF mutations in non-small cell lung cancer

Peter P. Luk, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina Selinger, Trina Lum, Steven Kao, Sandra A. O’Toole, Wendy A. Cooper

The suitability of small biopsy and cytology specimens for EGFR and other mutation testing in non-small cell lung cancer

Shu Wang, Bing Yu, Chiu Chin Ng, Belinda Mercorella, Christina I. Selinger, Sandra A. O’Toole, Wendy A. Cooper

Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice

Yunfen Wang, Yanwen Yao, Hongbin Liu, Xingqun Ma, Tangfeng Lv, Dongmei Yuan, Xinwu Xiao, Jie Yin, Yong Song

Ratio of maximum standardized uptake value to primary tumor size is a prognostic factor in patients with advanced non-small cell lung cancer

Fangfang Chen, Yanwen Yao, Chunyan Ma, Xingqun Ma, Zhaofeng Wang, Tangfeng Lv, Xinwu Xiao, Jie Yin, Yong Song

Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer

Dominic Maes, Jatinder Saini, Jing Zeng, Ramesh Rengan, Tony Wong, Stephen R. Bowen

The cytokinesis-blocked micronucleus assay as a novel biomarker for selection of lung cancer screening participants

Randa A. El-Zein, Carol J. Etzel, Reginald F. Munden

The use of TCP based EUD to rank and compare lung radiotherapy plans: in-silico study to evaluate the correlation between TCP with physical quality indices

Abdulhamid Chaikh, Jacques Balosso

Review Article

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Takashi Kohno, Takashi Nakaoku, Koji Tsuta, Katsuya Tsuchihara, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement

Hyojin Kim, Jin-Haeng Chung

Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer

Haoran Zhai, Wenzhao Zhong, Xuening Yang, Yi-Long Wu

Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations—a review

Erin L. Stewart, Samuel Zhixing Tan, Geoffrey Liu, Ming-Sound Tsao

Clinical trials for lung cancer in China

Fei-Yu Niu, Wen-Zhao Zhong, Qing Zhou, Yi-Long Wu

Recurrence after surgery in patients with NSCLC

Hidetaka Uramoto, Fumihiro Tanaka

Prognostic markers in lung cancer: is it ready for prime time?

Chang-Qi Zhu, Ming-Sound Tsao

Potential biomarkers for lung cancer screening

Gabriella Sozzi, Mattia Boeri

Particle therapy in non-small cell lung cancer

Zhongxing Liao, Charles B. Simone II

Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions

Ryan Clay, Srinivasan Rajagopalan, Ronald Karwoski, Fabien Maldonado, Tobias Peikert, Brian Bartholmai

Immunotherapy and radiation therapy for operable early stage and locally advanced non-small cell lung cancer

Neil K. Taunk, Andreas Rimner, Melissa Culligan, Joseph S. Friedberg, Julie Brahmer, Jamie Chaft

Combining immunotherapy and radiation therapy for small cell lung cancer and thymic tumors

Suchit H. Patel, Andreas Rimner, Roger B. Cohen

Intraoperative near-infrared imaging of mesothelioma

Gregory Thomas Kennedy, Andrew Newton, Jarrod Predina, Sunil Singhal

BAP1, a tumor suppressor gene driving malignant mesothelioma

Mitchell Cheung, Joseph R. Testa

Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation

Jonathan E. Schoenhals, Steven N. Seyedin, Clark Anderson, Eric D. Brooks, Yun R. Li, Ahmed I. Younes, Sharareh Niknam, Ailin Li, Hampartsoum B. Barsoumian, Maria Angelica Cortez, James W. Welsh

Diagnostic and prognostic biomarkers for malignant mesothelioma: an update

Zhongjian Chen, Giovanni Gaudino, Harvey I. Pass, Michele Carbone, Haining Yang

Immunotherapy for malignant pleural mesothelioma: current status and future directions

Jordan Dozier, Hua Zheng, Prasad S. Adusumilli

Biology and clinical significance of circulating tumor cell subpopulations in lung cancer

Linda O’Flaherty, Harriet Wikman, Klaus Pantel

Routine clinical use of circulating tumor cells for diagnosis of mutations and chromosomal rearrangements in non-small cell lung cancer—ready for prime-time?

Emma Pailler, Vincent Faugeroux, Marianne Oulhen, Cyril Catelain, Françoise Farace

Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer

Sumitra Mohan, Francesca Chemi, Ged Brady

Biophysical technologies for understanding circulating tumor cell biology and metastasis

Derrick W. Su, Jorge Nieva

Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer

Marianna Gallo, Antonella De Luca, Monica Rosaria Maiello, Amelia D’Alessio, Claudia Esposito, Nicoletta Chicchinelli, Laura Forgione, Maria Carmela Piccirillo, Gaetano Rocco, Alessandro Morabito, Gerardo Botti, Nicola Normanno

Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer

Salma K. Jabbour, Abigail T. Berman, Charles B. Simone II

Editorial

An alternative way to initiate Notch1 signaling in non-small cell lung cancer

Yi-Lin Yang, David Jablons, Liang You

Combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?

Fernando C. Santini, Siddharth Kunte, Alexander Drilon

Systematic Review and Meta-analysis

Association of the metformin with the risk of lung cancer: a meta-analysis

Li Wang, Yong Song, Guan-Nan Wu, Dong-Mei Yuan

China Lung Cancer Research Highlight

Dll4/Notch1 signaling from tip/stalk endothelial cell specification to stroma-dependent lung tumor inhibition: a flavor of Dll4/Notch1 pleiotropy in tumor cell biology

Maria Felice Brizzi, Paola Defilippi

Editorials

Dulanermin in cancer therapy: Still much to do

Cristina Quintavalle, Gerolama Condorelli

Review Articles

EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data

Bradley T. Clifford, Pingfu Fu, Nathan A. Pennell, Balazs Halmos, Rom S. Leidner

Copy number gains of FGFR1 and 3q chromosome in squamous cell carcinoma of the lung

Pedro Mendez, Jose Luis Ramirez

Role of HGF/MET axis in resistance of lung cancer to contemporary management

Kanwal Pratap Singh Raghav, Ana Maria Gonzalez-Angulo, George R. Blumenschein Jr

Circulating soluble intercellular adhesion Molecule-1 in lung cancer: a systematic review

Xiaoling Gu, Chunyan Ma, Dongmei Yuan, Yong Song

Ceritinib

Clinical development and approval of second generation ALK inhibitors for ALK rearranged lung cancer

Daniel B. Costa

Onartuzumab plus erlotinib

Targeting MET in NSCLC: looking for a needle in a haystack

Lorenza Landi, Federico Cappuzzo

Nivolumab

Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients with advanced non-small cell lung cancer

Arun Rajan, James L. Gulley

Brief Report

The role of Imaging and Radiation Oncology Core for precision medicine era of clinical trial

Ying Xiao, Mark Rosen

Review Article on Update on Pathology and Predictive Biomarkers of Lung Cancer

Biology of invasive mucinous adenocarcinoma of the lung

Yoon Jin Cha, Hyo Sup Shim

Immunohistochemistry for predictive biomarkers in non-small cell lung cancer

Mari Mino- Kenudson

Below are the latest Translational Lung Cancer Research articles published online ahead of print publication.

Currently no content available!

Journal Highlight more

Translational Lung Cancer Research is an international, peer-reviewed, open-access journal indexed by Science Citation Index Expanded (SCIE) and PubMed/PubMed Central, focusing on cutting-edge development on the transition from preclinical to clinical research, including but not limited to multimodality therapy, markers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to lung cancer and relevant thoracic diseases.